Treatment of attention-deficit hyperactivity disorder

Comment

Laurence Jerome. CMAJ. 2002.

. 2002 May 14;166(10):1251-2.

No abstract available

Comment on

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.
Schachter HM, Pham B, King J, Langford S, Moher D. Schachter HM, et al. CMAJ. 2001 Nov 27;165(11):1475-88. CMAJ. 2001. PMID: 11762571 Free PMC article.
Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder.
Vitiello B. Vitiello B. CMAJ. 2001 Nov 27;165(11):1505-6. CMAJ. 2001. PMID: 11762576 Free PMC article. Review. No abstract available.

1. Vitiello B. Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder [editorial]. CMAJ 2001;165(11):1505-6. - PMC - PubMed
1. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999;56:1073-86. - PubMed
1. Schacter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 2001;165(11):1475-88. - PMC - PubMed
1. Jerome L, Gordon M, Hustler P. A comparison of American and Canadian teachers' knowledge and attitudes towards attention deficit hyperactivity disorder (ADHD). Can J Psychiatry 1994;39: 563-7. - PubMed
1. Determining medical fitness to drive: a guide for physicians. 6th ed. Ottawa: Canadian Medical Association; 2000.